Lucid Diagnostics Current Valuation vs. Market Capitalization
| LUCD Stock | USD 1.00 0.02 2.04% |
For Lucid Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lucid Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lucid Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lucid Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lucid Diagnostics over time as well as its relative position and ranking within its peers.
Lucid |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.09 | Quarterly Revenue Growth 0.497 | Return On Assets (1.01) | Return On Equity (10.08) |
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lucid Diagnostics Market Capitalization vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Lucid Diagnostics's current stock value. Our valuation model uses many indicators to compare Lucid Diagnostics value to that of its competitors to determine the firm's financial worth. Lucid Diagnostics is rated below average in current valuation category among its peers. It also is rated below average in market capitalization category among its peers creating about 0.50 of Market Capitalization per Current Valuation. The ratio of Current Valuation to Market Capitalization for Lucid Diagnostics is roughly 1.98 . At present, Lucid Diagnostics' Market Cap is projected to decrease significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Lucid Diagnostics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Lucid Current Valuation vs. Competition
Lucid Diagnostics is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 17.05 Billion. Lucid Diagnostics maintains roughly 109.94 Million in current valuation contributing less than 1% to equities under Health Care industry.
Lucid Market Capitalization vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Lucid Diagnostics |
| = | 109.94 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Lucid Diagnostics |
| = | 55.45 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Lucid Market Capitalization vs Competition
Lucid Diagnostics is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 15.61 Billion. Lucid Diagnostics adds roughly 55.45 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Lucid Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Lucid Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lucid Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of Lucid Diagnostics' change in net profit over the period of time. It can combine multiple indicators of Lucid Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -16.8 B | -17.6 B | |
| Net Loss | -50.6 M | -48 M | |
| Operating Income | -48.5 M | -46.1 M | |
| Net Loss | -56.8 M | -53.9 M | |
| Income Before Tax | -52.7 M | -50 M | |
| Total Other Income Expense Net | -3.8 M | -3.6 M | |
| Net Loss | -52.7 M | -50 M | |
| Income Tax Expense | 2.3 M | 2.4 M | |
| Net Interest Income | -108 K | -113.4 K | |
| Interest Income | 424 K | 281.6 K | |
| Change To Netincome | 15.9 M | 16.7 M | |
| Net Loss | (1.26) | (1.32) | |
| Income Quality | 0.62 | 0.42 | |
| Net Income Per E B T | 0.92 | 0.82 |
Lucid Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Lucid Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lucid Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lucid Diagnostics' important profitability drivers and their relationship over time.
Use Lucid Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lucid Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lucid Diagnostics will appreciate offsetting losses from the drop in the long position's value.Lucid Diagnostics Pair Trading
Lucid Diagnostics Pair Trading Analysis
The ability to find closely correlated positions to Lucid Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lucid Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lucid Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lucid Diagnostics to buy it.
The correlation of Lucid Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lucid Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lucid Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lucid Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Lucid Diagnostics position
In addition to having Lucid Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Raw Materials Thematic Idea Now
Raw Materials
Companies that are involved with the development and processing of raw materials such as silver or forestry. The Raw Materials theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Raw Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
To fully project Lucid Diagnostics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Lucid Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Lucid Diagnostics' income statement, its balance sheet, and the statement of cash flows.